SCHEMBL24614719

SCHEMBL24614719

c1ccc(-c2c3ccccc3c(-c3cc4ccc5oc6ccccc6c5c4c4c3oc3ccccc34)c3cc(-c4ccc5ccccc5c4)ccc23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 2/20 0.36
PLA2G2A P14555 3/20 0.35
PLA2G4A P47712 3/20 0.35
CYP1A1 P04798 2/20 0.34
CYP1B1 Q16678 1/20 0.34
CYP1A2 P05177 2/20 0.34
CASP3 P42574 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
NPC1 O15118 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
RAB9A P51151 1/20 0.34
PLA2G10 O15496 1/20 0.34
PGR P06401 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
FYN P06241 1/20 0.33
MAPK3 P27361 1/20 0.33
AHR P35869 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24614721 0.95 PLA2G2A (0.38) PLA2G2APLA2G4ACYP1A1CYP1B1CYP1A2
SCHEMBL24614908 0.94 PLA2G2A (0.40) PLA2G2APLA2G4ACYP1A1CYP1B1CYP1A2
SCHEMBL24614754 0.94 PLA2G2A (0.40) PLA2G2APLA2G4ACYP1A1CYP1B1CYP1A2
SCHEMBL24614755 0.94 PLA2G2A (0.40) PLA2G2APLA2G4ACYP1A1CYP1B1CYP1A2
SCHEMBL24614743 0.94 GPR84 (0.38) GPR84PLA2G2APLA2G4ACYP1A1CYP1B1
SCHEMBL24614765 0.93 CA1 (0.35) PLA2G2APLA2G4ACYP1A1CYP1B1CYP1A2
SCHEMBL24614943 0.93 GPR84 (0.38) GPR84CYP1A1CYP1B1CYP1A2CASP3
SCHEMBL24614637 0.92 PLA2G2A (0.37) GPR84PLA2G2APLA2G4ACYP1A1CYP1B1
SCHEMBL24614670 0.91 PLA2G2A (0.40) GPR84PLA2G2APLA2G4ACYP1A1CYP1A2
SCHEMBL24474566 0.89 CA1 (0.39) PLA2G2APLA2G4ACYP1A1CYP1B1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220223801-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220223801-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES TMEM109, PIEZO1, L1CAM GPR84 3746/4885PLA2G2A 4420/4885PLA2G4A 4715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.